-+ 0.00%
-+ 0.00%
-+ 0.00%

SPRINGWORKS THERAPEUTICS RECEIVES POSITIVE CHMP OPINION FOR MIRDAMETINIB FOR TREATMENT OF ADULT AND PEDIATRIC PATIENTS WITH NF1-PN

Reuters·05/23/2025 12:00:58

Please log in to view news